| (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
替格瑞洛杂质I |
1644461-85-7 |
| Dabigatran Etexilate iMpurity |
达比加群酯杂质 |
1643377-48-3 |
| 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine |
4-氯-6,7-二氢-5H-吡咯并[2,3-D]嘧啶 |
16372-08-0 |
| N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide |
西那卡塞中间体 |
1005450-55-4 |
| N-[4-(β-Cyclohexylureidoethyl)benzensulfonyl] N'-Cyclohexylurea |
格列本脲(优降糖)杂质C |
10079-35-3 |
| 1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
西那卡塞杂质 |
1020414-33-8 |
| Trityl Olmesartan Medoxomil |
N2-硝基奥美沙坦酯 |
1020157-01-0 |
| (R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
(R)-(–)-2-氨基丁酰胺盐酸盐 |
103765-03-3 |
| 4-Hydroxy Omeprazole Sulfide |
埃索美拉唑有关物质 |
103876-98-8 |
| Levofloxacin Tetrafluoro Impurity 2 |
左氧氟沙星杂质Y |
103995-33-1 |
| 4-(2,3-DICHLORO-PHENYL)-2,6-DIMETHYL-1,4-DIHYDRO-PYRIDINE-3,5-DICARBOXYLIC ACID MONOMETHYL ESTER |
4-(2,3-二氯苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸单甲酯 |
105580-45-8 |
| Nateglinide Methyl Ester |
那格列奈甲酯 |
105746-47-2 |
| ApovincaMinic Acid Ethyl Ester N-Oxide |
长春西汀杂质18 |
109741-24-4 |
| (3R,5R)-Rosuvastatin |
(3R,5R)-罗伐他汀 |
1094100-06-7 |
| 6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine |
厄洛替尼杂质D |
1145671-52-8 |
| S-(+)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propylamide |
(S)-N,N-二甲基-3-羟基-3-(2-噻吩基)丙胺 |
116817-84-6 |
| Defluoro Levofloxacin |
左氧氟沙星去氟代杂质 |
117620-85-6 |
| 1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)- |
2-[ [(3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基]亚硫酰基]-1-(2,2,2-三氟乙基)-苯并咪唑 |
1187926-84-6 |
| 1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1229512-52-0 |
| 3-(3-hydroxypropyl)-7,8-dimethoxy-1,3-dihydro-2H-benzo[d]azepin-2-one |
伊伐布雷定杂质H |
1235547-06-4 |
QQ
